Prevalence of MS and NMOSD in Indigenous Populations Dependent on Ancestry
Investigators evaluated the occurrence of multiple sclerosis and neuromyelitis optica spectrum disorder in Australian and New Zealand Indigenous populations, comparing…
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies
By DocWire News Featured Reading -July 24, 2021 ABSTRACT Currently, there is still no cure for multiple sclerosis (MS), which…
Stuart Schlossman
Do you have #MS, but are unsure if you should have the COVID-19 vaccine?
Research study on MS & COVID-19 vaccine: Curious? Read more below READ THE CONSENT FORM About the Research Study…
Stuart Schlossman
MS Trial Evaluating ATA188 in Progressive MS
Evaluating ATA188 in Progressive MS: Jakob Dupont, MD, MA Part 2 of a phase 1, multicenter study evaluating the safety/tolerability,…
Stuart Schlossman
STEP for MS exercise study
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews…
Stuart Schlossman
Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French…
Click HERE to Subscribe for the MS Beacon eNewsletter Abstract Background: As healthcare management of highly active-relapsing-remitting multiple sclerosis (HA-RRMS) patients…
Stuart Schlossman
Bone marrow vs Wharton’s jelly mesenchymal stem cells in experimental sepsis: a comparative study
Abstract Background The use of mesenchymal stem cells (MSCs) is being extensively studied in clinical trials in the setting…
Stuart Schlossman
Data on T-cell Repertoire May Help in Understanding MS Development
by Marisa Wexler MS | June 16, 2021 Click HERE to Subscribe for the MS Beacon eNewsletter T-cells in the fluid around the…
Stuart Schlossman
Analysis Yields miRNA Linked With Atrophy in Patients With MS
June 3, 2021 – by: Jared Kaltwasser The new study identified altered microRNA (miRNA) in gray matter lesions, which could…
Stuart Schlossman
Study: Confirmed Disability Progression Provides Limited Predictive Value in MS
Confirmed disability progression is often used as a study endpoint to predict progression, but a new report says its predictive…
Stuart Schlossman
